Objective: To assess sleep-disordered breathing (SDB) in patients with acute stroke and its relationship to prestroke cerebrovascular disease, particularly leukoariosis. Methods: The authors studied SDB and CT evidence of prestroke cerebrovascular disease, nonacute brain infarction, and white matter disease (WMD) in 78 previously independent patients with acute stroke. Subjects underwent respiratory sleep studies to determine the Apnea-Hypopnea Index (AHI) and Desaturation Index (DI) 7 to 14 days following stroke. CT scans were evaluated for severity of acute prestroke cerebrovascular disease and WMD severity. Results: Prestroke cerebrovascular disease was present in 49 (63%) patients and was associated with worse SDB (mean AHI 35 vs 23, p Ͻ 0.01; mean DI 28 vs 18, p Ͻ 0.05), particularly in men (mean AHI 43 vs 27, p Ͻ 0.01). WMD severity correlated with AHI (r ϭ 0.26, p Ͻ 0.05) and age (r ϭ 0.56, p Ͻ 0.01). WMD severity in frontal and basal ganglia areas showed the strongest association. On multivariate analysis, WMD severity correlated independently with AHI (R 2 ϭ 0.07, p Ͻ 0.05). Conclusions: The presence of prestroke cerebrovascular disease and severity of WMD are associated with worse SDB. These findings suggest that either white matter is particularly vulnerable to the hypoxia and blood pressure variability associated with SDB or that WMD is a major factor exacerbating SDB following stroke. NEUROLOGY 2003;61:959 -963 From the Freeman Proportion with AHI Ͼ10, % (95% CI) 92 (86-98) Proportion with AHI Ͼ20, % (95% CI) 67 (56-78) Hypertension, % (95% CI) 48 (36-60) Ever smoked, % (95% CI) 41 (30-52) Diabetes, % (95% CI) 15 (7-23) Previous stroke or TIA (95% CI) 18 (9-27) SNSS ϭ Scandinavian Neurological Stroke Score; AHI ϭ Apnea-Hypopnea Index; DI ϭ Desaturation Index.
Previous studies have shown sleep-disordered breathing (SDB) in up to 95% of patients following acute stroke. 1 There is, however, little information on the relation between the location or extent of cerebrovascular disease and the severity of SDB. One recent study reported no association between SDB recorded during the first night after stroke and sleep history, infarct location, infarct size, or functional outcome. 2 It has been suggested that much of the SDB found following stroke predates the event. 3 We have previously reported that patients with lacunar strokes have worse SDB than those with cortical strokes, 4 a finding confirmed by another group. 5 These observations suggest that prestroke subcortical cerebrovascular disease might be a major factor accounting for the high prevalence of SDB following acute stroke. We hypothesized that in patients with recent acute stroke, the presence of prestroke cerebrovascular disease and the severity of white matter disease (WMD) rather than acute infarct location or extent of acute disease would be associated with worse SDB. We sought to determine whether CT evidence of prestroke cerebrovascular disease and WMD were associated with more severe SDB 1 to 2 weeks after acute stroke.
Subjects and methods. Subjects. Previously independent patients (Modified Rankin Score 6 Ͻ3) admitted with acute stroke to the Stroke Unit of Freeman Hospital, Newcastle upon Tyne, UK, underwent respiratory sleep studies 7 to 14 days following stroke onset while inpatients, as previously described. 4 Subjects with TIA, uncertain diagnosis, cognitive impairment or agitation prohibiting accurate sleep study, co-morbid disease or medication likely to interfere with the results of sleep studies, or who lived Ͼ5 miles from the hospital were excluded. Subjects who had previously experienced a stroke were not excluded provided that they had returned to independent living (Modified Rankin Score Ͻ3) afterward. Admission demographic data were collected, including age and prestroke handicap (Modified Rankin Handicap Score). 6 Stroke severity was measured using the Scandinavian Neurologic Stroke Score (SNSS) 7 at admission and week 2 after stroke. Level of disability at week 2 (Barthel Score) 8 was also determined for each subject. Informed consent was obtained from each subject (or their next of kin where a subject's communication was impaired) before performing the sleep study. The study was approved by the Newcastle Joint Ethics Committee.
Sleep studies. Studies were performed 7 to 14 days following stroke onset using the ResMed Autoset II plus system (Sydney, Australia) in diagnostic mode. 9 This equipment records airflow by nasal cannulas, arterial oxygen saturation (S a O 2 ) by a finger oximeter probe, chest movement by a thoracic resistance band, and body position. It was chosen because of patient tolerability and ease of placement/replacement of sensors in an acute stroke unit and because it permitted easy handling and pressure area care in hemiparetic patients.
A number of studies have validated the Autoset device in comparison with polysomnography, [9] [10] [11] and it has been used previously to diagnose SDB after stroke. 12, 13 Results were expressed as Apnea-Hypopnea Index (AHI), the frequency of apneas and hypopneas per hour of study. With the Autoset device, an apnea is recorded if the 2-second moving average ventilation falls to Ͻ25% of the recent average value (time constant 100 seconds) for at least 10 consecutive seconds; a hypopnea is defined as a decrease in nasal ventilation of at least 50% but Ͻ75% for at least 10 seconds; the level of oxygenation is not used in the definition. We also used the oximetry data from the device to determine the Desaturation Index (DI) for each subject. DI was defined as number of desaturations of Ն4%/hour of study.
CT scans. CT scans from each patient performed routinely on hospital admission were evaluated independently by two experienced CT radiologists: one a neuroradiologist with an interest in stroke and the other with an interest in cerebrovascular disease. CT scans of brain were performed within 72 hours of admission using a conventional Siemens Somatom ART scanner (Munich/ Erlangen, Germany). Scans were obtained as part of usual patient management using a protocol obtaining 5-mm slices at 5-mm intervals in the posterior fossa and 10-mm slices at 10-mm intervals in the rest of the brain; this was our normal brain-imaging protocol on this conventional scanner at the time of study. Patients with evidence of pathology other than stroke/cerebrovascular disease on CT were excluded from study.
The location and extent of the acute stroke and the presence and severity of prestroke cerebrovascular disease were assessed with the readers blind to the sleep study results, using two simple scales developed for the study (table 1). To assist CT interpretation, the readers were informed of the likely territory of the stroke using the Oxfordshire Community Stroke Project 14 classification. One radiologist had previously scored 40 of the CT scans using the same definitions 12 months previously. Inter-and intraobserver variability were determined. Prestroke scores were subsequently dichotomized in terms of the presence and absence of prestroke cerebrovascular disease. If there was disagreement between scores, the radiologists reviewed the films together and agreed on a final score.
To further evaluate the relations of SDB to prestroke cerebrovascular disease, scans were rated for extent and severity of the white matter component of prestroke disease (leukoaraiosis). This rating was performed by a single reader unaware of the sleep study results, using the previously validated Age-Related White Matter Change (ARWMC) Scale. 15, 16 Disease severity is scored between 0 and 3 in five areas (frontal, occipitoparietal, temporal, infratentorial, and basal ganglia) to give a total score between 0 and 15. Scoring was performed for the hemisphere unaffected by the acute stroke to ensure that only the effects of prestroke disease were assessed.
Statistical methods. Inter-and intraobserver agreement was assessed using Cohen's statistic. 17 Between-group comparisons were performed using the unpaired t-test and one-way analysis of variance. Associations between AHI, DI, age, admission SNSS, and acute/prestroke cerebrovascular disease scores and WMD were performed using Pearson's and Spearman's correlation coefficients and multiple linear regression analysis as appropriate. The 95% CI are used unless otherwise stated. SPSS 9.0 (Chicago, IL) was used to perform all statistics.
Results. Seventy-eight subjects (38 women) were studied (mean age 73 years, range 31 to 90 years). Patient characteristics are outlined in table 2. Agreement between the two radiologists on acute CT scores was only fair ( ϭ 0.35), with complete agreement on acute scores in 50% of the cases. The subsequent jointly agreed acute categorization showed no correlation (r ϭ 0.04, p ϭ 0.8) with severity of SDB. No difference in SDB severity was found between subjects with hemorrhage (n ϭ 7) vs infarction, and no relation was found between severity of SDB and location of acute stroke. Further analysis of acute cerebrovascular disease data was not pursued.
Agreement between prestroke scores was good ( ϭ 0.48) for nondichotomized (none, mild, or severe) scores and very good ( ϭ 0.73) for dichotomized scores (absent or present). Intraobserver agreement for nondichotomized scores was also good ( ϭ 0.59). Following joint review and scoring by both radiologists, 29 subjects (37% CI 26 to 48%) were reported to have no prestroke disease evident, 31 (40% CI 29 to 51%) had mild disease, and 18 (23% CI 12 to 34%) had severe disease. SDB was worse in subjects with prestroke cerebrovascular disease than in those with none (mean AHI 35 Ϯ 21 vs 23 Ϯ 10, p Ͻ 0.01; figure 1 ; mean DI 28 vs 18, p Ͻ 0.05) but did not differ between subjects with mild and severe disease (AHI 35 vs 35, DI 26 vs 31). Nevertheless, the severity of prestroke cerebrovascular disease correlated positively with AHI (r ϭ 0.24, p Ͻ 0.05) and DI (r ϭ 0.25, p Ͻ 0.05) as well as with age (r ϭ 0.48, p Ͻ 0.001) and prestroke Modified Rankin Score (r ϭ 0.38, p Ͻ 0.01, Spearman's coefficient). The correlation between AHI and age was not significant (r ϭ 0.19, p ϭ 0.09). No association was found between acute or prestroke WMD score and mean or nadir O 2 saturation.
Multiple regression analysis of factors potentially related to AHI was performed of presence or absence of prestroke cerebrovascular disease, age, and stroke severity at week 2 (SNSS); the only factor independently associated with AHI was the presence of prestroke cerebrovascular disease (R 2 ϭ 0.09, p ϭ 0.007). There were no significant relations between AHI and a history of hypertension, previ- Median prestroke Rankin (range) 1 (0-2)
Mean AHI (95% CI) 31 (27) (28) (29) (30) (31) (32) (33) (34) (35) Mean DI (95% CI) 24 (20) (21) (22) (23) (24) (25) (26) (27) (28) ous stroke, smoking, or diabetes. The possible effect of gender was analyzed separately (figure 2). SDB was worse in men with prestroke cerebrovascular disease (mean AHI 43 Ϯ 9 vs 23 Ϯ 5, p Ͻ 0.001) but not women (27 Ϯ 7 vs 23 Ϯ 5, p ϭ 0.4). The severity of WMD was assessed more specifically in 68 (87%) of scans, the remaining 10 scans being unavailable for this analysis. Subjects with WMD present (n ϭ 48) had worse SDB on average than those with no WMD (n ϭ 20; mean AHI 34 [CI 28 to 39] vs 23 [CI 18 to 29], p Ͻ 0.05). Again, the difference was more marked in men (mean AHI 39 [WMD] vs 24 [no WMD], p Ͻ 0.05) than women (mean AHI 28 vs 23, p ϭ 0.3). Total WMD score correlated with AHI (r ϭ 0.26, p Ͻ 0.05) and age (r ϭ 0.56, p Ͻ 0.01) but not with DI (r ϭ 0.16, NS). The strongest associations with AHI were seen for WMD severity in the frontal areas (r ϭ 0.29, p Ͻ 0.05) and basal ganglia (r ϭ 0.27, p Ͻ 0.05), although positive correlations existed for all areas. On multiple regression analysis of AHI with WMD severity, age, and week 2 stroke severity (SNSS), only WMD score was found to be independently associated (R 2 ϭ 0.07, p Ͻ 0.05) with severity of SDB. No correlation was found between ARWMC score and mean or nadir O 2 saturation.
Discussion.
The main findings of our study were that prestroke cerebrovascular disease and, more specifically, leukoaraiosis were associated with worse SDB after stroke, especially in men, and there was no association between SDB and the location of the acute stroke lesion on CT.
Our results do, however, require interpretation with caution owing to technical limitations. Following limited success with a portable polysomnography system (Compumedics P Series 2, Melbourne, Australia) in our population, we elected to use a limited sleep study system for better acceptability in dependent and potentially agitated patients. Previous investigators have also reported that cognitively impaired older subjects tolerate full polysomnography poorly, 18 and we wished to include such patients in our study to ensure our data were representative of stroke patients in the community and because these patients are more likely to have evidence of prestroke cerebrovascular disease. Previous studies 2, 19, 20 reporting the results of polysomnography after stroke have been performed in patients of lower average age and with less neurologic impairment. The Autoset system has been validated against polysomnography [9] [10] [11] in subjects with obstructive sleep apnea syndrome (OSAS), and this and other simplified sleep systems have been used in previous studies of SDB after stroke, 12, 13 but they have a number of disadvantages. As the system we used has only a single thoracic resistance band, paradoxical abdominal movement cannot be identified. Consequently, accurate distinction between types of apnea is often not possible, and thus we have not pursued this. Previous studies in which the types of events are identifiable have reported that the majority of apneas after stroke are obstructive. 2, 3 A further problem with all limited sleep study systems is that sleep duration and quality cannot be assessed. Indeed, because of this, "nocturnal disordered breathing" may be a more accurate description than "sleep-disordered breathing," but the latter is more commonly used even without EEG confirmation. As AHI and DI determined by limited systems are expressed in relation to study time rather than sleep time, their values will, if anything, tend to underestimate the severity of SDB. No previous studies have shown an association between severity of chronic disease and SDB. One study 20 reported worse than average SDB in subjects with acute posterior circulation strokes and intracerebral hemorrhage. Another, reporting a higher prevalence of SDB in subjects with multi-infarct dementia than in AD or similarly aged control subjects, 21 supports our finding that prestroke cerebrovascular disease is associated with SDB.
In apparent contrast to our observations, however, a recently published study of 45 nonstroke patients 22 with OSAS and age-matched control subjects reported no difference in severity of WMD using MRI. However, the subjects in this study were on average 22 years younger than in our study. These observations suggest that cerebrovascular disease is not a major cause or consequence of SDB in a younger symptomatic population. The apparent discrepancy is perhaps not surprising: As compared with younger individuals, the elderly typically show much higher rates of cardiovascular complications secondary to risk factors such as hypertension and atrial fibrillation. Another MR study 23 showed recently that subjects with obstructive sleep apnea had diminished gray matter in certain areas of the brain, but there was no significant effect on white matter. These subjects were again much younger (mean 49 years) than the typical patient with stroke. Our findings are not inconsistent with these, however, as our definition of prestroke disease also included cerebral atrophy.
The prestroke cerebrovascular disease reported on CT in our study comprised varying combinations of previous cerebral infarction, microvascular ischemic disease of the white matter, and cortical atrophy. We 4 and another group 5 have recently reported an association between SDB and lacunar stroke. This would be consistent with the hypothesis that it is the WMD component of chronic cerebrovascular disease that is specifically associated with SDB.
Whereas the current study demonstrates an association between WMD and SDB, the nature of this association is unclear. Cerebral white matter is more vulnerable than cortical gray matter to the effects of transient and persistent hypoxia, hypotension, and hypoperfusion, [23] [24] [25] and perfusion was recently shown to be reduced in areas of WMD. 26 Conversely, sustained hypertension is also known to be a cause of WMD through microvascular damage. 27 SDB and, in particular, the OSAS are associated with frequent nocturnal apneas with consequent episodic hypoxemia, and it is of note that we found higher DI in subjects with chronic cerebrovascular disease. OSAS is also associated with recurrent nocturnal and persistent daytime hypertension, increased sympathetic activation, reduced cerebral blood flow, and increased platelet activation, 3 any or all of which might predispose to both WMD and stroke.
A further possible explanation of our findings is that WMD might be associated with Cheyne-Stokes breathing, characterized by increased fluctuation of respiratory effort and ventilation 28 with consequent nocturnal apneas and hypopneas. Our recording system did not allow confident distinction of obstructive and central events, but this explanation is unlikely, as other studies 2,3 have shown that most events after stroke are obstructive.
The reason why men with WMD show more severe SBD than women is unclear. Overall the men in our study had more severe SDB than the women, as is usually found in studies of nocturnal breathing disorders. As the SDB was more severe in men, it may have been more likely to contribute to the etiology of WMD in men. We have previously reported that prestroke handicap is associated with the severity of SDB after stroke. 4 The finding of a significant correlation between prestroke Modified Rankin Score and prestroke cerebrovascular disease may account for this association.
The noncontrast CT scans of head used in this study were performed as a routine following admission for stroke and not specifically for the study. The scanning protocol used was the routine brain protocol suited to the CT scanner available in our institution at the time of study. The scales used to score acute and chronic disease were designed specifically for this study. Our objective was to produce a simple protocol that could be used quickly by an experienced radiologist. Most scans were reviewed together on completion of the study, when it was no longer possible to access the original images. This may in part explain the considerable discordance between scores for acute disease. However, previous studies of interobserver variability of interpretation of acute ischemic changes on CT have shown similarly poor agreement. 29 Agreement for chronic scores was substantially better, particularly when dichotomized to "present" and "absent." More accurate assessments of severity and distribution of acute and chronic WMD using MRI 30 would be of value in defining the relationship between white matter disease and SDB.
Unlike previous studies using the ARWMC Scale, 16, 17 we scored only the side unaffected by the acute lesion on the assumption that accurate distinction of prestroke disease in the presence of a large acute infarct or perihemorrhagic edema would have been compromised. This may have led to the over-or underscoring of subjects with previous unilateral lesions, but under the WMD scoring protocol, isolated lesions in any area score only 1 point and therefore have only a minor effect on the total.
In view of our findings, there is a need for a further study using MRI to quantify chronic cerebrovascular disease, perhaps in subjects with less severe strokes, better able to tolerate detailed polysomnography, and compared with appropriate age-matched control subjects.
